Journal of Oncology

Tumor Angiogenesis


Publishing date
01 May 2010
Status
Published
Submission deadline
01 Nov 2009

1Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA

2Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA

3Department of Biochemistry and Molecular Biology, Tumor Angiogenesis, Vascular Biology and Nanotechnology Laboratory, Mayo Clinic Foundation, Rochester, MN, USA


Tumor Angiogenesis

Description

For most cancers, if not all, angiogenesis is considered crucial for the progression of a localized tumor into an invasive cancer. Therapeutics targeting angiogenesis have been used successfully for the treatment of breast cancer, lung cancer, kidney cancer, and colon cancer. Recent reports, however, have provided evidence that clinical resistance to antiangiogenic agents can develop and that initial responses to these agents can lead to the development of more aggressive tumors. Early observations also indicate that lymphangiogenesis could promote tumor progression and pose a major challenge to the treatment of cancer with antiangiogenic therapy. The Journal of Oncology is, therefore, issuing an invitation to publish original research articles as well as review articles focusing on tumor vascularization and development of novel strategies targeting tumor angiogenesis and lymphangiogenesis.

Potential topics include but are not limited to:

  • Mechanisms contributing to the initial angiogenic switch in tumors
  • Influence of the tumor microenvironment on angiogenesis
  • Pericytes and vessel maturation in tumor angiogenesis
  • Molecular mechanisms of resistance to tumor antiangiogenic strategies
  • Tumor lymphangiogenesis as a potential therapeutic target
  • Role of lymphangiogenesis in tumor progression and resistance to antiangiogenic therapy
  • Mechanisms contributing to the development of aggressive tumors failing antiangiogenic therapy
  • Biological markers for predicting clinical response to antiangiogenic strategies
  • Radiological markers of tumor response
  • Mathematical models of the evolution of tumor vascularization
  • Antiangiogenic and vascular disrupting agents

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 761671
  • - Editorial

Tumor Angiogenesis

Arkadiusz Dudek | Kalpna Gupta | ... | Debabrata Mukhopadhyay
  • Special Issue
  • - Volume 2010
  • - Article ID 586905
  • - Review Article

Extracellular Matrix Proteins and Tumor Angiogenesis

N. E. Campbell | L. Kellenberger | ... | J. Petrik
  • Special Issue
  • - Volume 2010
  • - Article ID 928628
  • - Research Article

Inhibition of Melanoma Angiogenesis by Telomere Homolog Oligonucleotides

Christina Coleman | Danielle Levine | ... | David A. Goukassian
  • Special Issue
  • - Volume 2010
  • - Article ID 412985
  • - Review Article

Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls

J. E. Bohonowych | U. Gopal | J. S. Isaacs
  • Special Issue
  • - Volume 2010
  • - Article ID 939407
  • - Research Article

CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells

Minghuan Yu | Richard Berk | Mary Ann Kosir
  • Special Issue
  • - Volume 2010
  • - Article ID 961243
  • - Review Article

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer

Thomas N. Seyfried | Purna Mukherjee
  • Special Issue
  • - Volume 2010
  • - Article ID 652320
  • - Review Article

Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors

Grzegorz Korpanty | Laura A. Sullivan | ... | Rolf A. Brekken
  • Special Issue
  • - Volume 2010
  • - Article ID 732680
  • - Case Report

Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF

Angelo Corti | Monica Giovannini | ... | Eugenio Villa
  • Special Issue
  • - Volume 2010
  • - Article ID 272170
  • - Review Article

Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma

Paloma Sanz-Cameno | María Trapero-Marugán | ... | Ricardo Moreno-Otero
  • Special Issue
  • - Volume 2010
  • - Article ID 729725
  • - Review Article

Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies

Michael Medinger | Natalie Fischer | Alexandar Tzankov
Journal of Oncology
 Journal metrics
Acceptance rate33%
Submission to final decision94 days
Acceptance to publication49 days
CiteScore3.220
Impact Factor2.600
 Submit